A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis - Concepedia

Concepedia

Publication | Open Access

A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis

DOI Full Paper Access

212

Citations

15

References

2009

Year

Robert F. Betts, Márcio Nucci, Deepak Talwar, Marcelo Gareca, Flávio Queiroz‐Telles, Roger Bedimo, Raoul Herbrecht, Guillermo M. Ruiz‐Palacios, Jo‐Anne H. Young, John W. Baddley,

Clinical Infectious Diseases

Abstract

Both caspofungin dosing regimens were effective and well tolerated in patients with invasive candidiasis. No safety concerns were found for caspofungin at a dosage of 150 mg/day.

References

	Year	Citations

Page 1